Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgar T Overton

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Antiviral Therapy|July 22, 2015
Low bone mineral density and risk of incident fracture in HIV-infected adultsLinda Battalora, Kate Buchacz, Carl Armon, et al.
Scientific Reports|March 8, 2022
Optimization of methods for the accurate characterization of whole blood neutrophilsAshley N Connelly, Richard P H Huijbregts, Harish C Pal, et al.
AIDS (London, England)|June 26, 2024
Risk factors for progression from prediabetes to diabetes among older people with HIVMary Clare Masters, Katherine Tassiopoulos, Yajing Bao, et al.
American Journal of Hypertension|June 18, 2024
Association of Integrase Strand Transfer Inhibitor-Based Antiretroviral Therapy With Blood Pressure and Sustained Hypertension in People With Human Immunodeficiency VirusMohammed Siddiqui, Greer A Burkholder, Eric Judd, et al.
Vaccine|April 25, 2022
Safety and immunogenicity of monovalent H7N9 influenza vaccine with AS03 adjuvant given sequentially or simultaneously with a seasonal influenza vaccine: A randomized clinical trialJustin R Ortiz, Paul W Spearman, Paul A Goepfert, et al.
AIDS Research and Human Retroviruses|September 15, 2015
High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years Among HIV-Infected Persons in the Era of Modern Antiretroviral TherapyGerome V Escota, Kristin Mondy, Tim Bush, et al.
The Patient|May 31, 2021
Patient-Reported Outcomes Through 1 Year of an HIV-1 Clinical Trial Evaluating Long-Acting Cabotegravir and Rilpivirine Administered Every 4 or 8 Weeks (ATLAS-2M)Vasiliki Chounta, Edgar T Overton, Anthony Mills, et al.
The Journal of Infectious Diseases|July 10, 2020
Physical Function Impairment and Frailty in Middle-Aged People Living With Human Immunodeficiency Virus in the REPRIEVE Trial Ancillary Study PREPARETriin Umbleja, Todd T Brown, Edgar T Overton, et al.
The Journal of Infectious Diseases|November 18, 2021
COVID-19 Vaccination Rates in a Global HIV CohortEvelynne S Fulda, Kathleen V Fitch, Edgar T Overton, et al.
Sexually Transmitted Diseases|October 23, 2010
Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study)Erna Milunka Kojic, Susan Cu-Uvin, Lois Conley, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Antiviral Therapy|July 22, 2015
Low bone mineral density and risk of incident fracture in HIV-infected adultsLinda Battalora, Kate Buchacz, Carl Armon, et al.
Scientific Reports|March 8, 2022
Optimization of methods for the accurate characterization of whole blood neutrophilsAshley N Connelly, Richard P H Huijbregts, Harish C Pal, et al.
AIDS (London, England)|June 26, 2024
Risk factors for progression from prediabetes to diabetes among older people with HIVMary Clare Masters, Katherine Tassiopoulos, Yajing Bao, et al.
American Journal of Hypertension|June 18, 2024
Association of Integrase Strand Transfer Inhibitor-Based Antiretroviral Therapy With Blood Pressure and Sustained Hypertension in People With Human Immunodeficiency VirusMohammed Siddiqui, Greer A Burkholder, Eric Judd, et al.
Vaccine|April 25, 2022
Safety and immunogenicity of monovalent H7N9 influenza vaccine with AS03 adjuvant given sequentially or simultaneously with a seasonal influenza vaccine: A randomized clinical trialJustin R Ortiz, Paul W Spearman, Paul A Goepfert, et al.
AIDS Research and Human Retroviruses|September 15, 2015
High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years Among HIV-Infected Persons in the Era of Modern Antiretroviral TherapyGerome V Escota, Kristin Mondy, Tim Bush, et al.
The Patient|May 31, 2021
Patient-Reported Outcomes Through 1 Year of an HIV-1 Clinical Trial Evaluating Long-Acting Cabotegravir and Rilpivirine Administered Every 4 or 8 Weeks (ATLAS-2M)Vasiliki Chounta, Edgar T Overton, Anthony Mills, et al.
The Journal of Infectious Diseases|July 10, 2020
Physical Function Impairment and Frailty in Middle-Aged People Living With Human Immunodeficiency Virus in the REPRIEVE Trial Ancillary Study PREPARETriin Umbleja, Todd T Brown, Edgar T Overton, et al.
The Journal of Infectious Diseases|November 18, 2021
COVID-19 Vaccination Rates in a Global HIV CohortEvelynne S Fulda, Kathleen V Fitch, Edgar T Overton, et al.
Sexually Transmitted Diseases|October 23, 2010
Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study)Erna Milunka Kojic, Susan Cu-Uvin, Lois Conley, et al.
Pageof 10